Trans-splicing molecules
US-2026078380-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Bennett Jean patents
Bennett Jean is listed as an inventor on 66 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bennett Jean |
| Total patents | 66 |
| First publication | Apr 30, 2015 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions for treatment of wet age-related macular degeneration
US-12558434-B2 · Feb 24, 2026 · US
Neuroprotective gene therapy targeting the AKT pathway
US-12533423-B2 · Jan 27, 2026 · US
Trans-splicing molecules
US-12442003-B2 · Oct 14, 2025 · US
Methods and compositions for treatment of disorders and diseases involving RDH12
US-12419973-B2 · Sep 23, 2025 · US
Gene therapy for ocular disorders
US-12403204-B2 · Sep 2, 2025 · US
Methods, systems, and computer readable media for assessing visual function using virtual mobility tests
US-2025176822-A1 · Jun 5, 2025 · US
Trans-splicing molecules
US-2024318186-A1 · Sep 26, 2024 · US
Methods and compositions for treatment of ocular disorders and blinding diseases
US-12097267-B2 · Sep 24, 2024 · US
Gene therapy for ocular disorders
US-2024218394-A1 · Jul 4, 2024 · US
Recent patents
Latest publications not already listed above.
Trans-splicing molecules
US-11993776-B2 · May 28, 2024 · US
Gene therapy for ocular disorders
US-11879133-B2 · Jan 23, 2024 · US
Gene therapy for ocular disorders
US-11827898-B2 · Nov 28, 2023 · US
Gene therapy for treating peroxisomal disorders
US-11793887-B2 · Oct 24, 2023 · US
Gene therapy for ocular disorders
US-2023233709-A1 · Jul 27, 2023 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2023132391-A9 · Apr 27, 2023 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2023037283-A9 · Feb 2, 2023 · US
Gene therapy for ocular disorders
US-11564996-B2 · Jan 31, 2023 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2023009257-A1 · Jan 12, 2023 · US
Adeno-associated viruses and their uses for inner ear therapy
US-2022348957-A1 · Nov 3, 2022 · US
Triple helix terminator for efficient rna trans-splicing
US-2022204989-A1 · Jun 30, 2022 · US
Neuroprotective gene therapy targeting the akt pathway
US-2022143217-A1 · May 12, 2022 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2022118111-A1 · Apr 21, 2022 · US
Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
US-2022118110-A1 · Apr 21, 2022 · US
Compositions and Methods for Correction of Heritable Ocular Disease
US-2022062437-A1 · Mar 3, 2022 · US
Vision test for determining retinal disease progression
US-11206977-B2 · Dec 28, 2021 · US
Methods and compositions for treatment of disorders and diseases involving RDH12
US-11197936-B2 · Dec 14, 2021 · US
Gene therapy for ocular disorders
US-2021330816-A1 · Oct 28, 2021 · US
Gene therapy for ocular disorders
US-11090392-B2 · Aug 17, 2021 · US
Trans-splicing molecules
US-2021155938-A1 · May 27, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Pennsylvania | 66 |
| Ascidian Therapeutics Inc | 5 |
| Univ Florida | 3 |
| Mitchell Lloyd G | 3 |
| Inst Nat Sante Rech Med | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N15/86 | 53 |
| C12N2750/14143 | 53 |
| A61P27/02 | 40 |
| A61K48/005 | 37 |
| A61K48/00 | 37 |